YM-231146, a Novel Orally Bioavailable Inhibitor of Vascular Endothelial Growth Factor Receptor-2, Is Effective against Paclitaxel Resistant Tumors-Reference-Cited by-同舟云学术

YM-231146, a Novel Orally Bioavailable Inhibitor of Vascular Endothelial Growth Factor Receptor-2, Is Effective against Paclitaxel Resistant Tumors

Published:2005 Issue:11 Volume:28 Page:2096-2101
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Amino Nobuaki¹,Ideyama Yukitaka¹,Yamano Mayumi¹,Kuromitsu Sadao²,Tajinda Katsunori²,Samizu Kiyohiro³,Matsuhisa Akira⁴,Shirasuna Kenna⁵,Kudoh Masafumi¹,Shibasaki Masayuki¹

Affiliation:

1. Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

2. Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

3. Chemistry Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

4. Lead Discovery Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

5. Discovery Metabolism Research, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/28/11/28_11_2096/_pdf

Reference41 articles.

1. Cancer Undefeated

2. 2) Clynes M., “Multiple Drug Resistance in Cancer,” Kluwer Academic Publishers, Dordrecht, 1998.

3. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

4. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug delivery systems for colorectal cancer chemotherapy;Chinese Chemical Letters;2024-02

2. Regio- and diastereoselective construction of conjugate oxindole derivatives enabled by delayed acyl transfer of pyridinium ylides;Organic Chemistry Frontiers;2023

3. Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate;FEBS Open Bio;2020-06-18

4. A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype;Cancer Letters;2018-04

5. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer;Biomaterials;2013-08